WALDEN BEHAVIORAL CARE
1. Target Overview & Investment Thesis
WALDEN BEHAVIORAL CARE is a 51-bed suburban community hospital in SUFFOLK, MA with $46.8M in net patient revenue and a 12.8% operating margin. The hospital serves a payer mix of 5.3% Medicare, 22.3% Medicaid, and 72.4% commercial.
Thesis: Turnaround. Our ML models identify $3.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.8% to 20.2% (+736bps).
| Net Revenue HCRIS | $46.8M |
| Current EBITDA COMPUTED | $6.0M |
| Operating Margin COMPUTED | 12.8% |
| Occupancy HCRIS | 82.8% |
| Revenue / Bed COMPUTED | $917K |
| Net-to-Gross HCRIS | 46.8% |
| Distress Probability ML | 46.3% |
2. Market Context & Competitive Position
MA has 99 Medicare-certified hospitals with a median operating margin of -12.2%. The target's margin of 12.8% places it above the state median. Among 24 size-comparable peers (26-102 beds), the median margin is -11.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (26-102), prioritizing same-state peers. 24 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| WALDEN BEHAVIORAL CARE (Target) | MA | 51 | $46.8M | 12.8% |
| DANA-FARBER CANCER INSTITUTE | MA | 30 | $1.88B | -35.1% |
| MASSACHUSETTS EYE AND EAR INFI | MA | 41 | $263.9M | -36.1% |
| NEW ENGLAND BAPTIST HOSPITAL | MA | 75 | $221.2M | -4.6% |
| FALMOUTH HOSPITAL | MA | 81 | $172.1M | -2.2% |
| BIDMC-MILTON HOSPITAL INC | MA | 102 | $134.8M | -11.4% |
| BETH ISRAEL DEACONESS HOSPITAL | MA | 58 | $131.9M | -1.6% |
| BAYSTATE FRANKLIN MEDICAL CENT | MA | 89 | $98.1M | -23.1% |
| MARLBOROUGH HOSPITAL | MA | 67 | $94.2M | -21.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $982K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $936K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $926K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $569K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $30K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $6.0M |
| + RCM Uplift | +$3.4M |
| Pro Forma EBITDA | $9.4M |
| Current Margin | 12.8% |
| Pro Forma Margin | 20.2% |
| WC Released (1x) | $1.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $9.2M | $74.0M | 8.02x | 51.6% |
| Base (11x exit) | 10.0x | 11.0x | $9.2M | $84.4M | 9.14x | 55.7% |
| Bull Case | 9.0x | 11.0x | $8.3M | $98.8M | 11.89x | 64.1% |
| Bull (12x exit) | 9.0x | 12.0x | $8.3M | $110.2M | 13.26x | 67.7% |
| Bear Case | 11.0x | 10.0x | $10.2M | $53.8M | 5.30x | 39.6% |
| Bear (11x exit) | 11.0x | 11.0x | $10.2M | $62.5M | 6.15x | 43.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (22.3%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 24 hospitals with 26-102 beds
- Same-state prioritization (n=25)
- Comp margins: P25=-17.0% / P50=-11.4% / P75=-1.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.